Recent Biotechnology Acquisitions in Tennessee
Acquisition Volume in Biotechnology in Tennessee by Year
Last 5 years
-
February 16, 2022
- Buyer
- Tesis Biosciences
- Target
- Genome Explorations Inc.
- Industry
- Biotechnology
- Location
- Tennessee, United States
- Type
- Buyout
Tesis Biosciences has acquired Genome Explorations to accelerate its clinical research and product development efforts in targeted genetic sequencing and precision medicine. The acquisition brings Genome Explorations’ genomic profiling and molecular diagnostics capabilities and clinical research staff into Tesis’ integrated platform to speed development of proprietary therapeutics and diagnostic products.
-
February 17, 2021
- Buyer
- Charles River Laboratories International, Inc.
- Target
- Cognate BioServices, Inc.
- Seller
- EW Healthcare Partners, Medivate Partners, BlackRock, Unnamed sovereign wealth fund
- Industry
- Biotechnology
- Location
- Tennessee, United States
- Type
- Buyout
Charles River Laboratories agreed to acquire Cognate BioServices for approximately $875 million in cash, expanding Charles River's capabilities into the high-growth cell and gene therapy CDMO sector. Cognate, headquartered in Memphis, Tennessee with over 500 employees, will provide Charles River integrated cell and gene therapy development, testing, and CGMP manufacturing capabilities; the deal was expected to close by end of Q1 2021.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.